QBurst signs up a ground breaking project with AstraZeneca
QBurst joins hands with AstraZeneca, a global, integrated biopharmaceutical company, Dubai Division for handling their software solution requirements. AstraZeneca develops and manufactures market prescription medicines for many important areas of healthcare. They operate globally with their presence in Europe, Americas, Asia, Africa, and Australia.
As part of the first project, QBurst will be developing an iPad application for presenting Symbicort – Asthma combination treatment. The project kicks off the first phase on 28th of Septemer, 2010. The main objective of this iPad application is conversion of existing presentation and brochures for Symbicort into animated iPad format and static brochures.